Different aspects of driving under the influence of benzodiazepines
Experimental and epidemiological studies suggest a negative influence of benzodiazepines on driving skills, a dose-dependent impairment and an increased accident risk that can be concluded due to the doserelated impairment of reaction time, sedation and impairment of psychomotor function this group of drugs produce. [1] [2] [3] Nevertheless, determining the relation between benzodiazepines use and traffic accidents remains complex because of the many important selection factors that are doubtlessly present. 4 All published studies, experimental or epidemiological, provide conclusions that are heterogeneous and not robust enough to prove that such consumption represents a crash risk factor of significant magnitude. [5] [6] [7] Their results are conflicting due to differences in the methodology of determining drug use, different estimation of accident severity, lack of a dose-response relationship between the dose taken of a benzodiazepine and its effects on accident risk, and poor control for a significant number of confounding factors. [1] [2] [3] Epidemiological studies normally do not give conclusive results mainly due to methodological problems such as selection bias, small numbers of subjects, subjective elements that are involved in evaluating culpability and misclassification of the outcome. Failure to adjust for other significant confounders, such as fatigue, speed, tolerance, residual effect, concurrent alcohol consumption in combination with the lack of information about case history or about chronic or single dose, make things more difficult. [4] [5] [6] 8, 9 On the other hand, experimental studies have the disadvantage that they may not accurately predict the effects of drugs under actual driving conditions 9,10 and do not indicate the magnitude of the effect. 11 Due to ethical considerations, it is not possible to administer high enough benzodiazepine doses to obtain the benzodiazepine concentrations often found in real-life situations. The studies in most of the cases are single-dose experiments. The subjects included in experimental research are less often experienced users, excluding possible tolerance as a part of the studies. It could thus be argued that findings from such experimental studies would have limited relevance for real-life impairment that benzodiazepines can cause in experienced users. 12 An almost linear relationship between bloodbenzodiazepines concentration and its effects on driving ability seems to exist. 6, 13 However, the observation that benzodiazepines were usually detected at sub-therapeutic or therapeutic levels does not mean that drivers were unimpaired. 11 It is suggested that common therapeutic doses of certain benzodiazepines can impair skills associated with safe driving, and that this applies particularly to the longer-acting benzodiazepines when tested the morning after a night-time dose, and when subjects are tested within hours of a dose of most benzodiazepines. The shorter-acting benzodiazepines show little or no significant adverse effects on psychomotor skills the morning after a night-time dose. 14 The existing studies on the benzodiazepine concentration-impairment effect relationship opened the way for a discussion on legal limits for benzodiazepines in relation to driving. 5, 6, 13 More information is needed to establish blood concentration limits that indicate impairment of benzodiazepines and therefore are incompatible with driving behavior, and further experimental research is required 1 to elucidate the mechanisms underlying any observable driving impairment, and to address clinically relevant questions such as:
How does the long-term use of benzodiazepines affect driving ability? What are exactly the residual effects of benzodiazepine use on driving ability? What are the levels of impairment after low, therapeutic or sub-therapeutic doses of benzodiazepines?
Despite the non-conclusive results of the so far epidemiological and experimental studies on the benzodiazepines concentration-impairment relationship, some scientists have recommended the establishment of blood concentrations limits for driving after use of benzodiazepines as per se evidence of impairment. 6, 13 Until the establishment of such blood concentration limits for benzodiazepines, the zero tolerance approach seems to be the best way to deal with driving under the influence of these drugs, taking into account that the evaluation of the degree of the impairment at the moment of the accident is difficult. 15 Trained police officers should perform field sobriety tests and evaluate driving ability of an individual, while a specially trained physician should examine the suspect, look for signs and symptoms of drug influence and evaluate the degree of impairment right after the accident. It has to be mentioned here that as police officers are not able to detect disease or injury, medical input is always required. On the other hand, impairment by benzodiazepines is generally difficult to prove in court by standard sobriety tests due to the fact that these tests are somewhat insensitive for the assessment of the influence of drugs. 16 More studies on the relationship between dose, blood concentration and impairment effects are needed in order to establish limits indicating levels of impairment that are incompatible with driving. 6, 13 In any case, both physicians and pharmacists should advise their patients of the impairing effects of benzodiazepines, particularly in relation to drowsiness and sedation, and the implications of these effects on driving skills such as reaction time, attention and vigilance. 15 Patients should be prescribed evening doses of the shortest-acting hypnotics whenever possible. Patients who take longer-acting compounds or daytime doses of any hypnotic should be advised of the potential for impairment, even in the absence of subjective symptoms. These patients should also be advised to avoid driving, particularly during the initial phase of dosage adjustments.
